MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology_Drug & Vaccine Discovery and Development
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP)
Organization & Developments: Adamis
Parents
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP)
Children
2011: UCSD, Harvard license cancer vaccine technology to Adamis Pharmaceuticals (2011)
2017: 2 ~$5 Biotechs To Buy Here_Pieris, Adamis
2017: 2 Small Biopharma CEOs That Should Be Sacked_ Adamis
2017: Adamis Pharmaceuticals: Updates To Thesis - Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)
2018: Adamis Looks Cheap Despite Serious Leadership Concerns_seekingalpha.com
2018: Adamis Offers A Rare Business Update_seekingalpha.com
2018: Adamis Pharmaceuticals: The Latest Update Still Keeps Us Waiting - Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)
2018: Adamis Pharmaceuticals: The Long Wait Is Over - Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)
2018: Adamis: Here We Go Again!_seekingalpha.com
2018: Adamis: Sandoz Is Ready To Challenge EpiPen Dominance - Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)
2018: Oversold Adamis May Rise, Lifting Spirits Of Patients And Investors Alike - Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)
2018: Time Is Nearly Up For Adamis_seekingalpha.com
2018: Time To Get Onboard Adamis?_seekingalpha.com
2018: What Is Adamis Worth?_seekingalpha.com
2018" Adamis Finally Delivers!_seekingalpha.com
2019: Adamis Pharmaceuticals Is Poised For A Sharp Rebound - Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)
2019: Adamis-Emerge Partnership Displeases Investors_seekingalpha.com
2019: Adamis: Cuts Op-Ex And Prepares For 'Zimhi' Approval_seekingalpha.com
2019: Patience Will Be Required For Sandoz And Adamis' 'Phased' Launch Of Symjepi_seekingalpha.com
2021: Adamis Pharmaceuticals: Locking In Profits While Riding On The Back Of A Phoenix
2021: Adamis Pharmaceuticals: TEMPOL's Near-Term And Long-Term Upside Improves As Variants Sidestep Vaccines
2022: Adamis Pharmaceuticals: Managing A Position In A Company Diagnosed With Chronic Failure_seekingalpha.com
2022: Penny stock player to review all options to try staying afloat after clinical trial fail
Providing low-cost, novel drug delivery solutions in respiratory disease and allergies
Subsidiaries: U.S. Compounding, Inc., Adamis Laboratories Inc, International Laboratories Inc., Adamis Viral Therapies Inc.
Jumps
*Key People: Adamis
Finance & Acquisitions: Adamis